论文部分内容阅读
目的探讨炎性脱髓鞘疾病的临床治疗方法及效果。方法选取濮阳油田总医院收治的炎性脱髓鞘疾病患者,随机分为甲泼尼龙组及地塞米松组,采用视觉疼痛模拟量表(VAS)评价两组疼痛并观察比较其临床疗效。结果甲泼尼龙组患者经治疗后疼痛程度比地塞米松组患者更轻,且甲泼尼龙组患者的临床疗效显著优于地塞米松组,结果差异具有统计学意义(P<0.05)。结论甲泼尼龙对炎性脱髓鞘疾病的临床治疗效果显著优于地塞米松,更具临床应用价值。
Objective To investigate the clinical treatment of inflammatory demyelinating diseases and its effects. Methods The patients with inflammatory demyelinating diseases admitted in Puyang Oilfield General Hospital were randomly divided into methylprednisolone group and dexamethasone group. Visual acuity analog scale (VAS) was used to evaluate the pain and to compare the clinical curative effect. Results The patients in methylprednisolone group received lighter pain after dexamethasone treatment than those in dexamethasone group. The clinical efficacy of methylprednisolone group was significantly better than that of dexamethasone group. The difference was statistically significant (P <0.05). Conclusion The clinical effect of methylprednisolone on inflammatory demyelinating disease is better than that of dexamethasone, which is of clinical value.